See more : XP Inc. (XPVVV) Income Statement Analysis – Financial Results
Complete financial analysis of Mindset Pharma Inc. (MSSTF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mindset Pharma Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Beacon Minerals Limited (BCN.AX) Income Statement Analysis – Financial Results
- Warteck Invest AG (WARN.SW) Income Statement Analysis – Financial Results
- AMJ Land Holdings Limited (AMJLAND.NS) Income Statement Analysis – Financial Results
- PPC Ltd (PPC.JO) Income Statement Analysis – Financial Results
- Ashford Hospitality Trust, Inc. (AHT-PH) Income Statement Analysis – Financial Results
Mindset Pharma Inc. (MSSTF)
About Mindset Pharma Inc.
Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.
Metric | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|
Revenue | 3.91M | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 3.91M | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 100.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 7.39M | 2.22M | 0.00 | 0.00 |
General & Administrative | 13.09M | 6.24M | 45.62K | 13.95K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 13.09M | 6.24M | 45.62K | 13.95K |
Other Expenses | -33.41K | -71.37K | 0.00 | 0.00 |
Operating Expenses | 20.48M | 8.46M | 45.62K | 13.95K |
Cost & Expenses | 20.48M | 8.46M | 45.62K | 13.95K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 44.53K | 22.26K | 171.86K | 161.14K |
EBITDA | -16.53M | -5.32M | -58.15K | -13.95K |
EBITDA Ratio | -423.29% | 0.00% | 0.00% | 0.00% |
Operating Income | -16.58M | -5.35M | -58.15K | -13.95K |
Operating Income Ratio | -424.43% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -33.41K | -6.31M | 25.04K | 0.00 |
Income Before Tax | -16.61M | -11.65M | -33.10K | -13.95K |
Income Before Tax Ratio | -425.29% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 3.12M | 0.00 | 0.00 |
Net Income | -16.61M | -11.65M | -33.10K | -13.95K |
Net Income Ratio | -425.29% | 0.00% | 0.00% | 0.00% |
EPS | -0.18 | -0.20 | 0.00 | 0.00 |
EPS Diluted | -0.18 | -0.20 | 0.00 | 0.00 |
Weighted Avg Shares Out | 90.06M | 57.66M | 66.14M | 66.14M |
Weighted Avg Shares Out (Dil) | 90.06M | 57.66M | 66.14M | 66.14M |
Mindset Pharma Engages KCSA Strategic Communications to Provide Investor Relations Services
Mindset Pharma Announces Exercise of Over-Allotment Option for Additional Gross Proceeds of $1.052 Million
Mindset Pharma Announces Closing of $7.5 Million Bought Deal Public Offering
Mindset Pharma Announces Filing of Amended and Restated FS and MD&A for the Three and Six Month Period Ended December 31, 2020
Source: https://incomestatements.info
Category: Stock Reports